DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients

Diabetes and Metabolism

Volumn 36, Issue 1, 2010, Pages 51-57

  Arif, M ^a   Islam, M R ^a   Waise, T M Z ^a   Hassan, F ^a   Mondal, S I ^b   Kabir, Y ^c  

^a UNIVERSITY OF DHAKA   (Bangladesh)

^b SHAHJALAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Bangladesh)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Comet assay; DNA; Malondialdehyde; Oxidative stress; Protein carbonyl; Protein thiol; Superoxide dismutase; Type 2 diabetes mellitus

Indexed keywords

CARBONYL DERIVATIVE; DNA; GLUCOSE; MALONALDEHYDE; OXIDIZING AGENT; PROTEIN CARBONYL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL PROTEINASE; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BANGLADESH; COMET ASSAY; CONTROLLED STUDY; DIABETIC PATIENT; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; SPECTROPHOTOMETRY;

ADULT; AGED; ANTIOXIDANTS; BANGLADESH; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COMET ASSAY; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 76449111364     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.05.007     Document Type: Article

References (37)

1. Palanduz S., Ademoglu E., Gokkusu C., and Tamer S. Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol 109 (2001) 309-318
2. Mills E.M., Takeda K., Yu Z.X., Ferrans V., Katagiri Y., Jiang H., et al. Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC12 cells. J Biol Chem 273 (1998) 22165-22168
3. Dursun E., Ozben T., Suleymanlar G., Dursun B., and Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 40 (2002) 1009-1013
4. Klemm A., Voigt C., Friedrich M., Fünfstück R., Sperschneider H., Jäger E.G., et al. Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance. Nephrol Dial Transplant 16 (2001) 2166-2171
5. Garibaldi S., Aragno I., Odetti P., and Marianari U.M. Relationships between protein carbonyls, retinol, and tocopherols levels in human plasma. Biochem Mol Biol Int 34 (1994) 729-736
6. Samir M., and el Kholy N.M. Thiobarbituric acid reactive substances in patients with laryngeal cancer. Clin Otolaryngol Allied Sci 24 (1999) 232-234
7. Stadtman E.R., and Levine R.L. Protein oxidation. Ann NY Acad Sci 899 (2000) 191-208
8. Cakatay U., Telci A., Kayali R., Tekeli F., Akcay T., and Sivas A. Relation of aging with oxidative protein damage parameters in the rat skeletal muscle. Clin Biochem 36 (2003) 51-55
9. Carrard G., Bulteau A.L., Petropoulos I., and Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34 (2002) 1461-1474
10. Benzi G., and Moretti A. Are reactive oxygen species involved in Alzheimer's disease?. Neurobiol Aging 16 (1995) 661-674
11. Shigenaga M.K., and Ames B.N. Assays for 8-hydroxy-2- deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med 10 (1991) 211-216
12. Aruoma O.I., Halliwell B., and Dizdaroglu M. Iron ion-dependentmodification of bases in DNA by the superoxide radical-generating system hypoxanthine/xanthine oxidase. J Biol Chem 264 (1989) 13024-13028
13. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35 (2000) 206-221
14. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson, Clay P., et al. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 18 (2003) 45-51
15. Colak E., Majkic-Singh N., Stankovic S., Srecković-Dimitrijevic V., Djordjevic P.B., Lalic K., et al. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 37 (2005) 613-620
16. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular disease. J Hypertens 18 (2000) 655-673
17. Nadin S.B., Vargas-Roig L.M., and Ciocca D.R. A silver staining method for single-cell gel assay. J Histochem Cytochem 49 (2001) 1183-1186
18. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
19. Chakraborty H., Ray S., and Chakrabarti S. Lipid peroxidation associated protein damage in rate crude synaptosomal fraction mediated by iron and ascorbate. Neurochem Int 39 (2001) 311-317
20. Habeeb A.F.S.A. Reaction of protein sulphydryl groups with Ellman's reagent. Methods Enzymol 25 (1972) 457-464
21. Beauchamp P.C., and Fridovich I. Super oxide dismutase: Improved assay and an assay applicable to PAGE. Anal Biochem 44 (1971) 276-287
22. Chan W.B., Tong P.C., Chow C.C., So W.Y., Ng M.C., Ma R.C., et al. Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients. Diabetes Metab Res Rev 21 (2005) 183-188
23. Pan H.Z., Zhang H., Chang D., Li H., and Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92 (2008) 548-551
24. Yu B.J., and Cho H.C. The activity of erythrocyte antioxidant enzymes in diabetes mellitus. Korean J Int Med 44 (1993) 766-774
25. Komosińska-Vassev K., Olczyk K., Olczyk P., and Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 68 (2005) 207-216
26. Kesavulu M.M., Giri R., Kameswara Rao B., and Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 26 (2000) 387-392
27. Michiels C., Raes M., Toussaint O., and Remacle J. Importance of Se-glutathione peroxidase, catalase and Cu/Zn SOD for cell survival against oxidative stress. Free Radic Biol Med 17 (1994) 235-248
28. Domingues C., Ruiz E., Gussinye M., and Carrascosa A. Oxidative stress at onset and in early stages of type I Diabetes in children and adolescents. Diabetes Care 21 (1998) 1736-1742
29. Pasaoglu H., Sancak B., and Bukan N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med 203 (2004) 211-218
30. Akkus I., Kalak S., Vural H., Caglayan O., Menekşe E., Can G., et al. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244 (1996) 221-227
31. Kesavulu M.M., Rao B.K., Giri R., Vijya J.S., Subramanyam G., and Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 53 (2001) 33-39
32. Kajanachumpol S., Komindr S., and Mahaisiriyodom A. Plasma lipid peroxide and antioxidant levels in diabetic patients. J Med Assoc Thai 80 (1997) 372-377
33. Stadtman E.R., and Berlett B.S. Reactive oxygen-mediated protein oxidation in aging anddisease. Drug Metab Rev 30 (1998) 225-243
34. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31 (2005) 551-557
35. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 347 (1996) 444-445
36. Lodovici M., Giovannelli L., Pitozzi V., Bigagli E., Bardini G., and Rotella C.M. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res 638 (2008) 98-102
37. Choi S.W., Benzie I.F., Lam C.S., Chat S.W., Lam J., Yiu C.H., et al. Inter-relationships between DNA damage, ascorbic acid and glycaemic control in type 2 diabetes mellitus. Diabet Med 22 (2005) 1347-1353